GENERIC NAME OF THE MEDICINAL PRODUCT:
2. Daclatasvir Tablets 60mg (DAKLITAJ)
3. Daclatasvir Tablets 90mg (DAKLITAJ)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film-coated tablet contains:
Daclatasvir Dihydrochloride
Equivalent to Daclatasvir …………….30mg
Excipients………………………………. q. s
Color: Sunset yellow FCF
2. Daclatasvir Tablets 60mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride
Equivalent to Daclatasvir …………….60mg
Excipients………………………………. q. s
Color: Sunset yellow
3. Daclatasvir Tablets 90mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride
Equivalent to Daclatasvir …………….90mg
Excipients………………………………. q. s
Color: Sunset yellow lake
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
FIND ABOUT THE MEDICINE THAT SHOULD NOT BE TAKEN WITH DACLATASVIR.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Store in dry place protected from light and moisture.
DOSAGE: As directed by the Hepatologists.
Attach dispensing label as per end country.
Daclatasvir Tablets 30mg Technical Specification:
| Product Name: | Daclatasvir Tablets |
| Brand Name: | DAKLITAJ |
| Strength: | (30mg), (60mg), (90mg) |
| Dosage Form: | Tablets (film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Hepatitis C Treatment |
| Indication: | Daclatasvir is used to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors |
| Storage: | Store at 20° to 25°C (68° to 77°F). See USP controlled room temperature. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
1. Daclatasvir Tablets 30mg (DAKLITAJ)
2. Daclatasvir Tablets 60mg (DAKLITAJ)
3. Daclatasvir Tablets 90mg (DAKLITAJ)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
1. Daclatasvir Tablets 30mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride
Equivalent to Daclatasvir …………….30mg
Excipients………………………………. q. s
Color: Sunset yellow FCF
2. Daclatasvir Tablets 60mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride
Equivalent to Daclatasvir …………….60mg
Excipients………………………………. q. s
Color: Sunset yellow
3. Daclatasvir Tablets 90mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride
Equivalent to Daclatasvir …………….90mg
Excipients………………………………. q. s
Color: Sunset yellow lake
THERAPEUTIC INDICATIONS:
Daclatasvir is used to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors
CAUTION & WARNING:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
Find about the medicine that should not be taken with daclatasvir.
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
STORAGE: Store at 20° to 25°C (68° to 77°F). See USP controlled room temperature.
Store in dry place protected from light and moisture.
DOSAGE: As directed by the Hepatologists.
Introduction to Daclatasvir Tablets 30mg (DAKLITAJ)
Daclatasvir Tablets 30mg (DAKLITAJ) is a prescription antiviral medicine used in combination with other agents such as Sofosbuvir to treat chronic Hepatitis C virus (HCV) infection in adults. Belonging to the NS5A inhibitor class, Daclatasvir works by blocking the viral replication process, preventing the virus from multiplying in liver cells.
The brand DAKLITAJ, manufactured by Taj Pharma, stands for reliability, global standards, and clinical efficacy. Other equivalent brands include Daklinza, Dacihep, Hepcdac, etc.
Daclatasvir 30mg is not used alone; it must be combined with other antivirals to ensure complete suppression of the Hepatitis C virus. It is most effective for genotype 1 and 3 infections, reducing viral load and improving liver health.
With the global rise in Hepatitis C treatment demand, Taj Pharma India has emerged as the top manufacturer and exporter of Daclatasvir Tablets 30mg (DAKLITAJ), providing cost-effective therapy for developing and regulated markets alike.
2. In-Depth Details for Importers, Exporters, and Global Buyers
Taj Pharma’s Daclatasvir Tablets 30mg (DAKLITAJ) are manufactured under stringent WHO-GMP and EU-GMP certified facilities at Vapi, Gujarat, India. Global buyers benefit from comprehensive technical and regulatory support for seamless import and market authorization.
Regulatory Documentation Provided
-
Certificate of Pharmaceutical Product (COPP)
-
WHO-GMP Certification
-
Certificate of Analysis (COA)
-
Stability Data
-
Bioequivalence Study (if applicable)
-
Drug Master File (DMF)
-
Common Technical Document (CTD Dossier)
-
Free Sale Certificate (FSC)
-
Manufacturing License
Custom Packaging & Labelling
Taj Pharma offers private labeling, multilingual packaging, and custom branding services to suit different country regulations.
Packaging options include:
-
1×28 Tablets / 1×14 Tablets per pack
-
Alu-Alu or Blister Pack with moisture protection
-
Customized outer cartons and leaflets per export market needs.
Shelf-life, Storage & Dosage Form
-
Dosage Form: Film-coated tablet
-
Strength: 30mg of Daclatasvir dihydrochloride
-
Shelf Life: 24–36 months (depending on market regulations)
-
Storage Conditions: Store below 30°C, protect from moisture and direct sunlight.
Export Certifications
Taj Pharma’s Daclatasvir Tablets 30mg (DAKLITAJ) comply with global regulatory norms:
-
WHO-GMP (World Health Organization – Good Manufacturing Practices)
-
EU-GMP (European Union standards)
-
COPP (Certificate of Pharmaceutical Product for export)
-
CTD/ACTD Dossier available
-
ISO 9001:2015 Certified manufacturing site
Target Countries & Export Markets
Taj Pharma actively exports Daclatasvir Tablets 30mg (DAKLITAJ) to:
-
Asia: Philippines, Vietnam, Myanmar, Nepal, Bangladesh
-
Africa: Nigeria, Kenya, Ghana, Uganda, South Africa, Ethiopia
-
Middle East: UAE, Yemen, Saudi Arabia, Iraq, Iran
-
Latin America: Peru, Bolivia, Ecuador
-
CIS & Eastern Europe: Uzbekistan, Kazakhstan, Ukraine
Taj Pharma ensures timely delivery, regulatory-compliant labeling, and competitive pricing, making it a trusted supplier for tenders, hospitals, and private importers.
3. Why Taj Pharma is the Most Trusted Manufacturer, Supplier, and Exporter
a. State-of-the-Art Manufacturing
Taj Pharma’s WHO-GMP-certified manufacturing facility in Vapi, Gujarat, is equipped with advanced production lines, cleanroom infrastructure, and automated packaging units.
Strict in-process quality checks, microbial testing, and stability studies ensure every batch of Daclatasvir Tablets 30mg (DAKLITAJ) meets international safety and efficacy standards.
b. Affordable Pricing & Quality Assurance
Taj Pharma believes in “Healthcare for All” by offering affordable, world-class antivirals without compromising quality.
Their quality assurance follows:
-
ISO 9001:2015 and GLP standards
-
Pharmacopoeia compliance (IP/BP/USP/EP)
-
Regular audits by international clients and regulatory authorities
c. Global Presence & Supply Chain Support
Taj Pharma serves over 80 countries, supporting clients with:
-
End-to-end regulatory documentation
-
Tender participation support
-
Custom clearance assistance
-
Cold chain & global logistics management
The company’s well-established export network ensures uninterrupted supply, even in high-demand global markets.
d. Top 20 Export Countries
USA, UK, South Africa, Kenya, Nigeria, Ghana, Vietnam, Myanmar, Philippines, Bangladesh, Sri Lanka, Iraq, Yemen, Uzbekistan, Kazakhstan, Georgia, Peru, Bolivia, Ukraine, Cambodia
These export relationships underline Taj Pharma’s reputation as the #1 Daclatasvir Tablets 30mg (DAKLITAJ) Manufacturer & Exporter from India.
4. Technical Product Specification Table
| Product Name | Daclatasvir Tablets 30mg (DAKLITAJ) |
|---|---|
| Active Ingredient | Daclatasvir Dihydrochloride |
| Strength | 30mg |
| Form | Film-coated Tablet |
| Pack Size | 1×14 / 1×28 Tablets |
| Therapeutic Use | Chronic Hepatitis C treatment |
| Mechanism of Action | NS5A Inhibitor – Blocks viral replication |
| Combination Therapy | Sofosbuvir ± Ribavirin |
| Route of Administration | Oral |
| Storage | Below 30°C, dry place |
| Shelf Life | 24–36 Months |
| Manufacturer | Taj Pharma Ltd., Vapi, Gujarat, India |
| Certifications | WHO-GMP, ISO 9001:2015, COPP, CTD Dossier Available |
| Export Markets | Asia, Africa, Middle East, Latin America, CIS |
| Brand Names | DAKLITAJ, Daklinza, Dacihep, Hepcdac |
| Side Effects | Headache, Fatigue, Nausea, Insomnia, Diarrhea |
5. Call to Action
Looking for a reliable Daclatasvir Tablets 30mg (DAKLITAJ) Manufacturer in India for your local market or government tender?
Taj Pharma Ltd offers unmatched:
-
Global regulatory dossier support
-
Contract manufacturing and private labeling
-
WHO-GMP-certified production
-
On-time international shipping
Contact Taj Pharma Today to get your quotation and samples for Daclatasvir Tablets 30mg (DAKLITAJ).
📧 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com
🏭 Manufacturing Site: Vapi, Gujarat, India
6. Top 20 FAQs
Q1. What is Daclatasvir Tablets 30mg (DAKLITAJ) used for?
A1. It’s used in combination with Sofosbuvir to treat chronic Hepatitis C virus infection in adults.
Q2. Who manufactures Daclatasvir Tablets 30mg in India?
A2. Taj Pharma Ltd, a WHO-GMP-certified manufacturer from Vapi, Gujarat, India.
Q3. Is Daclatasvir taken alone?
A3. No, it must be used with other antiviral drugs like Sofosbuvir for best results.
Q4. How should Daclatasvir Tablets be taken?
A4. Swallow whole, with or without food. Do not crush or chew.
Q5. What are the side effects?
A5. Common side effects include headache, nausea, fatigue, diarrhea, and insomnia.
Q6. Can Daclatasvir be used in all HCV genotypes?
A6. It is effective mainly in genotype 1 and 3 HCV infections.
Q7. Is Daclatasvir available for export?
A7. Yes, Taj Pharma exports to over 80 countries globally.
Q8. Does Taj Pharma provide regulatory support?
A8. Yes, full CTD dossier, COPP, and COA are available.
Q9. Is Daclatasvir affordable in developing nations?
A9. Taj Pharma ensures competitive pricing for global accessibility.
Q10. What certifications does Taj Pharma hold?
A10. WHO-GMP, ISO, COPP, and EU-GMP certifications.
Q11. What is the shelf life?
A11. Typically 24–36 months.
Q12. Can Taj Pharma supply under a buyer’s brand?
A12. Yes, private labeling and OEM manufacturing are available.
Q13. How to store Daclatasvir Tablets?
A13. Store below 30°C, away from moisture.
Q14. What packaging options are available?
A14. Alu-Alu / Blister packs with multilingual outer cartons.
Q15. What’s the mechanism of action?
A15. Daclatasvir inhibits the NS5A protein, blocking HCV replication.
Q16. What countries import from Taj Pharma?
A16. Kenya, Vietnam, Nepal, Philippines, UAE, Nigeria, and more.
Q17. Is a prescription required?
A17. Yes, Daclatasvir is a prescription-only antiviral drug.
Q18. Does Taj Pharma offer PCD Pharma Franchise?
A18. Yes, nationwide PCD and third-party manufacturing options are available.
Q19. Is Taj Pharma an Indian or global brand?
A19. Taj Pharma is an Indian multinational pharmaceutical company with a global footprint.
Q20. How can I import Daclatasvir Tablets 30mg (DAKLITAJ)?
A20. Contact Taj Pharma’s export division via www.tajpharma.com for quotations and required documentation.






